文献速递心脑血管急症重症综合管理与镇静镇痛

感染性心内膜炎危重患者的脑血管并发症与结局

Cerebrovascular complications and outcomes of critically ill adult patients with infective endocarditis.
PubMed 文献 · Ann Intensive Care · 2022-12-30
一句话结论危重感染性心内膜炎患者中,中重度缺血性卒中独立降低1年良好功能结局(OR 0.37),颅内出血无此影响。

这项回顾性队列研究纳入2011年6月1日至2018年7月31日一家三级医院内科ICU连续收治的156例重症左侧感染性心内膜炎患者,按基线头颅CT分为正常、中重度缺血性卒中、轻微缺血性卒中、颅内出血和其他异常五类。87/156(56%)存在CT定义的神经系统并发症;1年时69例(45%)获得良好结局(改良Rankin量表0-3分)。多变量分析显示中重度缺血性卒中(OR 0.37,95%CI 0.14-0.95)和年龄(OR 0.94,95%CI 0.91-0.97)与良好结局负相关,格拉斯哥昏迷评分每增加1分与良好结局正相关(OR 1.23,95%CI 1.08-1.42)。手术患者敏感性分析结果相似,且中重度缺血性卒中组术后神经系统并发症更多(8/23(35%)vs 1/46(2%),p<0.01)。

要点

  • 危重左侧感染性心内膜炎患者中56%(87/156)存在CT定义的神经系统并发症,中重度缺血性卒中占21%(33/156)。
  • 中重度缺血性卒中独立降低1年良好功能结局(改良Rankin量表0-3分):OR 0.37,95%CI 0.14-0.95。
  • 年龄与良好结局负相关(OR 0.94,95%CI 0.91-0.97),格拉斯哥昏迷评分每增1分与良好结局正相关(OR 1.23,95%CI 1.08-1.42)。
  • 颅内出血(24/156,15%)与1年功能结局无独立关联。
  • 手术患者中,中重度缺血性卒中组术后神经系统并发症发生率高于CT正常组:8/23(35%)vs 1/46(2%),p<0.01。

适用人群与场景

  • 一家三级医院内科ICU连续收治的成人重症左侧感染性心内膜炎患者。
  • 排除无基线头颅CT的患者。

诊断标准与关键阈值

  • 基线头颅CT分为五类互斥类别:正常、中重度缺血性卒中、轻微缺血性卒中、颅内出血、其他异常CT。
  • 主要终点为1年良好结局,定义为改良Rankin量表评分0-3分。

研究设计与关键结果

  • 回顾性队列研究,纳入156例患者,中重度缺血性卒中33/156(21%)、颅内出血24/156(15%)、轻微缺血性卒中29/156(19%)、其他异常3/156(2%)。
  • 1年时69/156(45%)患者获得良好结局。
  • 多变量分析:中重度缺血性卒中OR 0.37(95%CI 0.14-0.95)、年龄OR 0.94(95%CI 0.91-0.97)与良好结局负相关;格拉斯哥昏迷评分每增1分OR 1.23(95%CI 1.08-1.42)与良好结局正相关。
  • 手术患者敏感性分析结果相似。
  • 与CT正常相比,仅中重度缺血性卒中与更频繁的术后神经系统并发症相关:8/23(35%)vs 1/46(2%),p<0.01。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,在危重感染性心内膜炎患者中,中重度缺血性卒中对1年功能结局有独立负面影响,而包括颅内出血在内的其他并发症无此影响。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Neurological complications are associated with poor outcome in patients with infective endocarditis (IE). Although guidelines recommend systematic brain imaging in the evaluation of IE patients, the association between early brain imaging findings and outcomes has never been evaluated in critically ill patients. We aimed to assess the association of CT-defined neurological complications with functional outcomes of critically ill IE patients.

METHODS: This retrospective cohort study included consecutive patients with severe, left-sided IE hospitalized in the medical ICU of a tertiary care hospital. Patients with no baseline brain CT were excluded. Baseline CT-scans were classified in five mutually exclusive categories (normal, moderate-to-severe ischemic stroke, minor ischemic stroke, intracranial hemorrhage, other abnormal CT). The primary endpoint was 1-year favorable outcome, defined by a modified Rankin Scale score of 0-3.

RESULTS: Between 06/01/2011 and 07/31/2018, 156 patients were included. Among them, 87/156 (56%) had a CT-defined neurological complication, including moderate-to-severe ischemic stroke (n = 33/156, 21%), intracranial hemorrhage (n = 24/156, 15%), minor ischemic stroke (n = 29/156, 19%), other (n = 3/156, 2%). At one year, 69 (45%) patients had a favorable outcome. Factors negatively associated with favorable outcome in multivariable analysis were moderate-to-severe ischemic stroke (OR 0.37, 95%CI 0.14 - 0.95) and age (OR 0.94, 95%CI 0.91-0.97). By contrast, the score on the Glasgow Coma Scale was positively associated with favorable outcome (per 1-point increment, OR 1.23, 95%CI 1.08-1.42). Sensitivity analyses conducted in operated patients revealed similar findings. Compared to normal CT, only moderate-to-severe ischemic stroke was associated with more frequent post-operative neurological complications (n = 8/23 (35%) vs n = 1/46 (2%), p < 0.01).

CONCLUSION: Moderate-to-severe ischemic stroke had an independent negative impact on 1-year functional outcome in critically ill IE patients; whereas other complications, including intracranial hemorrhage, had no such impact.

来源:Ann Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Rambaud T, de Montmollin E, Jaquet P, et al. Cerebrovascular complications and outcomes of critically ill adult patients with infective endocarditis. Ann Intensive Care. 2022. PMID: 36583809. doi:10.1186/s13613-022-01086-6

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。